The strength of its GLP-1 business suggests the stock still has more room to run.

Dow Jones Futures Rise; SpaceX, AMD Dive As Arista, Eli Lilly Jump With S&P 500 At Highs

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbust…

Novo Nordisk's shares fell 4.3% after raising its full-year guidance, as investors remain worried about pricing pressures and growth in its obesity drug segmen…

Baron Capital , an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to d…

At Holdings Channel , we have reviewed the latest batch of the 57 most recent 13F filings for the 06/30/2026 reporting period, and noticed that Eli Lilly (Symb…

Written by Sara Appino for The Motley Fool -> Abbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition …

Written by Prosper Junior Bakiny for The Motley Fool -> Expanding the GLP-1 market with new launches and label expansions will help Eli Lilly overcome increas…

Dow Jones Futures: Market Rebounds, Now Watch For This; SpaceX, AMD, Sandisk, Eli Lilly Earnings Loom

Written by Matthew Benjamin for The Motley Fool -> Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obe…

Written by Prosper Junior Bakiny for The Motley Fool -> Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects,…